DUBLIN, Calif., Oct. 11 /PRNewswire-FirstCall/ -- SuperGen Inc. today announced that James S. Manuso, Ph.D., President and Chief Executive Officer, will present a corporate overview and highlight SuperGen's recent developments at the 2006 BIO InvestorForum, at 2 p.m. PDT, on Oct. 18, 2006, at the Palace Hotel in San Francisco.
A live Webcast of Dr. Manuso's presentation will be available on the Investor Relations section of the Company's website at www.supergen.com. The Webcast will be archived for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen is a pharmaceutical company dedicated to the discovery, acquisition, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on inhibitors of aurora-A, tyrosine kinase and DNA methyltransferase. For more information about SuperGen, please visit http://www.supergen.com.
Contacts: SuperGen Noonan Russo Timothy L. Enns Sharon Weinstein, S.V.P., Corporate Communications (212) 845-4271 (Investors) & Business Development sharon.weinstein@eurorscg.com (925) 560-0100 x111 tenns@supergen.com Tracey Milani, (858) 546-4811 (Media) tracey.milani@eurorscg.com
SuperGen Inc.CONTACT: Timothy L. Enns, S.V.P., Corporate Communications & BusinessDevelopment, SuperGen, +1-925-560-0100 x111, tenns@supergen.com; Investors- Sharon Weinstein, +1-212-845-4271, sharon.weinstein@eurorscg.com, orMedia - Tracey Milani, +1-858-546-4811, tracey.milani@eurorscg.com, both ofNoonan Russo for SuperGen
Web site: http://www.supergen.com/
